SG Americas Securities
FHTX icon

SG Americas Securities’s Foghorn Therapeutics FHTX Stock Holding History

SG Americas Securities’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,118
Closed -$44K – 3155
2025
Q1 		$44K Buy
12,118
+720
+6% +$3.28K ﹤0.01% 3266
2024
Q4 		$54K Buy
11,398
+746
+7% +$5.43K ﹤0.01% 2894
2024
Q3 		$99K Buy
+10,652
New +$77.1K ﹤0.01% 3086
2022
Q1 		– Sell
-4,624
Closed -$106K – 3114
2021
Q4 		$106K Sell
4,624
-6,301
-58% -$90.6K ﹤0.01% 3059
2021
Q3 		$152K Buy
+10,925
New +$121K ﹤0.01% 3427

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

SG Americas Securities's FHTX Position: Q2 2025 in Review

SG Americas Securities sold out of Foghorn Therapeutics (FHTX) in Q2 2025, closing a stake of 12,118 shares — an estimated $44K sold.

SG Americas Securities first reported a position in FHTX in Q3 2021 and held it in 5 quarters. The position peaked at $152K in Q3 2021. 81 funds tracked by Wall St. Rank hold FHTX as of Q2 2025.

  • SG Americas Securities reported no remaining Foghorn Therapeutics position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 12,118 Foghorn Therapeutics shares in Q2 2025, an estimated $44K.
  • SG Americas Securities first reported a position in Foghorn Therapeutics in Q3 2021 and held it in 5 quarters.
  • SG Americas Securities's Foghorn Therapeutics position peaked at $152K in Q3 2021.
  • 81 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.